Recent Advancements in Non-Small Cell Lung Cancer
Bilal Piperdi, MD, discusses the recent advancements in non-small cell lung cancer treatment and what the future might bring.
Bilal Piperdi, MD, Associate Professor of Clinical Medicine, Department of Medicine (Oncology), Albert Einstein College of Medicine, discusses the recent advancements in non-small cell lung cancer treatment and what the future might bring.
Clinical Pearls:
- There have been improvements in molecular testing
- Physicians have learned that it is not just the histology that determines the biology of these patients; it is different mutations that define the biology of this disease
- More advances in molecular testing would allow for clinicians to test for multiple mutations at a time, including some of the uncommon mutations
- The challenge in the future will be learning how the different mutations interact and what targets can better treat the cancer
Recent Videos
Related Content
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024Article
In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
